Prolactin and endocrine therapy resistance in breast cancer: The next potential hope for breast cancer treatment

Breast cancer, a hormone‐dependent tumour, generally includes four molecular subtypes (luminal A, luminal B, HER2 enriched and triple‐negative) based on oestrogen receptor, progesterone receptor and human epidermal growth factor receptor‐2. Multiple hormones in the body regulate the development of b...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuan, Kong, Xiangyi, Xuan, Lixue, Wang, Zhongzhao, Huang, Yen‐Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581311/
https://www.ncbi.nlm.nih.gov/pubmed/34651424
http://dx.doi.org/10.1111/jcmm.16946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581311/
https://www.ncbi.nlm.nih.gov/pubmed/34651424
http://dx.doi.org/10.1111/jcmm.16946

Ejemplares similares